The most recent and futuristic technological developments in the field will be presented at the Innovations in Cardiovascular Interventions (ICI) conference next month in Tel Aviv.
Mr. Rigby is the Group Chief Executive Officer of Revolo Biotherapeutics and has three decades of experience in the pharmaceutical and biotechnology industries SAN DIEGO and CALGARY, AB